109 related articles for article (PubMed ID: 12960257)
1. Role of CD40 ligand dysregulation in HIV-associated dysfunction of antigen-presenting cells.
Chougnet C
J Leukoc Biol; 2003 Nov; 74(5):702-9. PubMed ID: 12960257
[TBL] [Abstract][Full Text] [Related]
2. The emerging role of CD40 ligand in HIV infection.
Kornbluth RS
J Leukoc Biol; 2000 Sep; 68(3):373-82. PubMed ID: 10985254
[TBL] [Abstract][Full Text] [Related]
3. CD40 activation: lessons for HIV immunotherapy from malignancies?
Le Dieu R; Gribben J
J HIV Ther; 2005 Sep; 10(3):51-5. PubMed ID: 16385972
[TBL] [Abstract][Full Text] [Related]
4. Role of CD40 ligand signaling in defective type 1 cytokine response in human immunodeficiency virus infection.
Subauste CS; Wessendarp M; Smulian AG; Frame PT
J Infect Dis; 2001 Jun; 183(12):1722-31. PubMed ID: 11372024
[TBL] [Abstract][Full Text] [Related]
5. Potential immaturity of the T-cell and antigen-presenting cell interaction in cord blood with particular emphasis on the CD40-CD40 ligand costimulatory pathway.
Han P; McDonald T; Hodge G
Immunology; 2004 Sep; 113(1):26-34. PubMed ID: 15312133
[TBL] [Abstract][Full Text] [Related]
6. Human immunodeficiency virus type 1-anchored CD40 ligand induces secretion of the chemokine interleukin-8 by human primary macrophages.
Maurais E; Cantin R; Tremblay MJ
Virology; 2009 Mar; 385(1):227-32. PubMed ID: 19101003
[TBL] [Abstract][Full Text] [Related]
7. B-cell expansion in the presence of the novel 293-CD40L-sCD40L cell line allows the generation of large numbers of efficient xenoantigen-free APC.
Ivanov R; Aarts T; Hagenbeek A; Hol S; Ebeling S
Cytotherapy; 2005; 7(1):62-73. PubMed ID: 16040385
[TBL] [Abstract][Full Text] [Related]
8. CD40 ligand dysregulation in HIV infection: HIV glycoprotein 120 inhibits signaling cascades upstream of CD40 ligand transcription.
Zhang R; Fichtenbaum CJ; Hildeman DA; Lifson JD; Chougnet C
J Immunol; 2004 Feb; 172(4):2678-86. PubMed ID: 14764743
[TBL] [Abstract][Full Text] [Related]
9. CD40 signaling regulates innate and adaptive activation of microglia in response to amyloid beta-peptide.
Townsend KP; Town T; Mori T; Lue LF; Shytle D; Sanberg PR; Morgan D; Fernandez F; Flavell RA; Tan J
Eur J Immunol; 2005 Mar; 35(3):901-10. PubMed ID: 15688347
[TBL] [Abstract][Full Text] [Related]
10. Use of CD40L immunoconjugates to overcome the defective immune response to vaccines for infections and cancer in the aged.
Tang YC; Thoman M; Linton PJ; Deisseroth A
Cancer Immunol Immunother; 2009 Dec; 58(12):1949-57. PubMed ID: 19444444
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous activation of viral antigen-specific memory CD4+ and CD8+ T-cells using mRNA-electroporated CD40-activated autologous B-cells.
Van den Bosch GA; Van Gulck E; Ponsaerts P; Nijs G; Lenjou M; Apers L; Kint I; Heyndrickx L; Vanham G; Van Bockstaele DR; Berneman ZN; Van Tendeloo VF
J Immunother; 2006; 29(5):512-23. PubMed ID: 16971807
[TBL] [Abstract][Full Text] [Related]
12. CD40 ligand is selectively expressed on CD4+ T cells and platelets: implications for CD40-CD40L signalling in atherosclerosis.
Büchner K; Henn V; Gräfe M; de Boer OJ; Becker AE; Kroczek RA
J Pathol; 2003 Oct; 201(2):288-95. PubMed ID: 14517846
[TBL] [Abstract][Full Text] [Related]
13. B cells play a cooperative role via CD40L-CD40 interaction in T cell-mediated experimental autoimmune neuritis in Lewis rats.
Zhu W; Mix E; Jin T; Adem A; Zhu J
Neurobiol Dis; 2007 Mar; 25(3):642-8. PubMed ID: 17188497
[TBL] [Abstract][Full Text] [Related]
14. Human immunodeficiency virus type 1-associated CD40 ligand transactivates B lymphocytes and promotes infection of CD4+ T cells.
Martin G; Roy J; Barat C; Ouellet M; Gilbert C; Tremblay MJ
J Virol; 2007 Jun; 81(11):5872-81. PubMed ID: 17392362
[TBL] [Abstract][Full Text] [Related]
15. Disruption of CD40-CD40 ligand pathway inhibits the development of intestinal muscle hypercontractility and protective immunity in nematode infection.
Khan WI; Motomura Y; Blennerhassett PA; Kanbayashi H; Varghese AK; El-Sharkawy RT; Gauldie J; Collins SM
Am J Physiol Gastrointest Liver Physiol; 2005 Jan; 288(1):G15-22. PubMed ID: 15308470
[TBL] [Abstract][Full Text] [Related]
16. In this issue: harnessing immunity against difficult targets, through the CD40-CD40L pathway.
Kornbluth RS; Bot A
Int Rev Immunol; 2012 Aug; 31(4):243-5. PubMed ID: 22804569
[TBL] [Abstract][Full Text] [Related]
17. B cells can prime naive CD4+ T cells in vivo in the absence of other professional antigen-presenting cells in a CD154-CD40-dependent manner.
Rodríguez-Pinto D; Moreno J
Eur J Immunol; 2005 Apr; 35(4):1097-105. PubMed ID: 15756646
[TBL] [Abstract][Full Text] [Related]
18. CD40-CD40 ligand interactions in oxidative stress, inflammation and vascular disease.
Rizvi M; Pathak D; Freedman JE; Chakrabarti S
Trends Mol Med; 2008 Dec; 14(12):530-8. PubMed ID: 18977174
[TBL] [Abstract][Full Text] [Related]
19. The immunobiology of CD154-CD40-TRAF interactions in atherosclerosis.
Engel D; Seijkens T; Poggi M; Sanati M; Thevissen L; Beckers L; Wijnands E; Lievens D; Lutgens E
Semin Immunol; 2009 Oct; 21(5):308-12. PubMed ID: 19616449
[TBL] [Abstract][Full Text] [Related]
20. Antitumor immunity against bladder cancer induced by ex vivo expression of CD40 ligand gene using retrovirus vector.
Kimura T; Ohashi T; Kikuchi T; Kiyota H; Eto Y; Ohishi Y
Cancer Gene Ther; 2003 Nov; 10(11):833-9. PubMed ID: 14605669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
